CLINICAL_TRIALS
trial_result
· 2021-04-05
Clinical Trial Update: Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine [Phase 4]
Summary
Phase 4 trial evaluating how extended dose intervals affect the immune response to an oral cholera vaccine completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Cholera, Vibrio Cholerae Infection | Phase 4 | Status: COMPLETED